94 results
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
4 May 23
Ligand Reports First Quarter 2023 Financial Results
4:06pm
in a
study of postmenopausal women with locally advanced or metastatic estrogen receptor-positive ER+/HER2- breast cancer with an ESR1 mutation
8-K
EX-99.1
sl9rxk
7 Nov 22
Ligand Reports Third Quarter 2022 Financial Results
4:04pm
8-K
EX-99.1
u47b8cp6x8jx26
8 Aug 22
Ligand Reports Second Quarter 2022 Financial Results
4:06pm
8-K
EX-99.1
vkkek 0bhjakxl5qkw0k
17 Feb 22
Ligand Reports Fourth Quarter and Full Year 2021 Financial Results
4:03pm
8-K
EX-99.1
tfdt329dha04wn1bb
20 Oct 20
Results of Operations and Financial Condition
10:52am
8-K
EX-99.1
cc5ji7pcd nhzztiki2
12 Mar 19
Regulation FD Disclosure
10:02am
8-K
EX-99.1
4mka67za
7 Feb 19
Ligand Reports Fourth Quarter and Full Year 2018 Financial Results
4:16pm
8-K
EX-99.1
au38pp5fev0rruwvil
8 Nov 18
Ligand Reports Third Quarter 2018 Financial Results
8:13am